Complete response to third-line treatment with trifluridine/tipiracil (TAS-102) in stage IV colon adenocarcinoma

  1. Lara-Morga, C.
  2. Palka-Kotlowska, M.
  3. Custodio-Cabello, S.
  4. Pacheco-Barcia, V.
  5. Cabezón-Gutiérrez, L.
Journal:
Exploration of Targeted Anti-tumor Therapy

ISSN: 2692-3114

Year of publication: 2023

Volume: 4

Issue: 2

Pages: 307-315

Type: Article

DOI: 10.37349/ETAT.2023.00136 GOOGLE SCHOLAR lock_openOpen access editor

Sustainable development goals

Data source: Scopus